Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XM17 versus Gonal-f in women undergoing assisted reproductive technologies
ISRCTN74772901Phase 3Completed
- Sponsor
- BioGeneriX AG
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial of follitropin and follitropin alfa in infertility (2 arms), sponsored by BioGeneriX AG. Primary endpoint: Number of cumulus oocyte complexes retrieved. Started Mar 2010; status: completed.
02
Drugs
follitropinfollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on ISRCTN74772901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74772901.